MACLAUGHLAN TODD EWEN 4
4 · WATSON PHARMACEUTICALS INC · Filed Aug 5, 2003
Insider Transaction Report
Form 4
MACLAUGHLAN TODD EWEN
VP, Business Development
Transactions
- Award
Incentive Stock Options
2003-08-04$38.92/sh+6,700$260,764→ 6,700 totalExercise: $38.92From: 2004-08-04Exp: 2013-08-04→ Common Stock (6,700 underlying)
Holdings
- 500
Common Stock, par value $0.0033
Footnotes (1)
- [F1]These stock options become exercisable in five annual installments of 1,340 each commencing on August 4, 2004.